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Abstract
Purpose: This study aimed to present guidance on the correlation between treat-
ment nozzle and proton source parameters, and dose distribution of a passive dou-
ble scattering compact proton therapy unit, known as Mevion S250.
Methods: All 24 beam options were modeled using the MCNPX MC code. The cal-
culated physical dose for pristine peak, proﬁles, and spread out Bragg peak (SOBP)
were benchmarked with the measured data. Track‐averaged LET (LETt) and dose‐av-
eraged LET (LETd) distributions were also calculated. For the sensitivity investiga-
tions, proton beam line parameters including Average Energy (AE), Energy Spread
(ES), Spot Size (SS), Beam Angle (BA), Beam Offset (OA), and Second scatter Offset
(SO) from central Axis, and also First Scatter (FS) thickness were simulated in differ-
ent stages to obtain the uncertainty of the derived results on the physical dose and
LET distribution in a water phantom.
Results: For the physical dose distribution, the MCNPX MC model matched measure-
ments data for all the options to within 2 mm and 2% criterion. The Mevion S250 was
found to have a LETt between 0.46 and 8.76 keV.μm–1 and a corresponding LETd
between 0.84 and 15.91 keV.μm–1. For all the options, the AE and ES had the greatest
effect on the resulting depth of pristine peak and peak‐to‐plateau ratio respectively.
BA, OA, and SO signiﬁcantly decreased the ﬂatness and symmetry of the proﬁles. The
LETs were found to be sensitive to the AE, ES, and SS, especially in the peak region.
Conclusions: This study revealed the importance of considering detailed beam
parameters, and identifying those that resulted in large effects on the physical dose
distribution and LETs for a compact proton therapy machine.
K E Y WORD S
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1 | INTRODUCTION
Proton therapy using compact passively scattered systems is undergo-
ing a technological evolution as it eliminates the requirement for a
complex beam transport system.1 However, additional absorbers are
added to the gantry due to the lack of an energy selection system in a
relatively short beamline. These absorbers signiﬁcantly complicate the
modeling of the system and justify careful characterization with precise
and accurate methods to identify beam parameters, i.e. proton source
that affect the uncertainty of calculated proton dose distributions.2
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Received: 5 September 2019 | Revised: 31 October 2019 | Accepted: 2 December 2019
DOI: 10.1002/acm2.12803
26 | wileyonlinelibrary.com/journal/jacmp J Appl Clin Med Phys 2020; 21:2:26–37
On the other hand, beside the proton physical dose distribution, its
relative biological effectiveness (RBE) should also be taken into
account.3–5 However, according to recent publications,3,6 there is a sig-
niﬁcant variability in the RBE of protons as a function of depth or parti-
cle energy in the beam. In radiation dosimetry, linear energy transfer
(LET) is one of the fundamental variables employed to derive the RBE.7
According to the recently published AAPM TG‐256, voxel‐by‐voxel
dose‐averaged LET can be employed as a valuable tool for biologically
optimized treatment planning even without knowing dose‐ and tissue
endpoint‐speciﬁc RBE values accurately.4 Therefore, it is important to
provide accurate proton LET distributions with rigorous sensitivity anal-
ysis, in addition to the physical dose, for clinical applications.
Monte Carlo (MC) simulation, as a gold standard tool in simulat-
ing complex radiation transport,8 plays an increasingly important role
in proton therapy.9–11 Moreover, MC calculated LET values can be
efﬁciently employed in the optimization of proton treatment plan-
ning systems (TPS) for clinical applications.12 Considering these
advantages, MC simulation “can be an alternative or complimentary
source of dosimetric data for developing, conﬁguring, and validating
analytical dose algorithms in clinical TPS”.1
In order to derive physical dose and LET distributions of a proton
therapy unit by MC simulations, all major mechanical components of
the treatment nozzle should be modeled in detail.9,13,14 However, even
detailed simulation of all machine components cannot account for devi-
ations, especially for the radiation source, from factory speciﬁca-
tions.11,15,16 Furthermore, the source information provided by the
manufacturer is often limited to spot size and nominal energy, and cus-
tomization of the MC model is required to match its results with the
measured data.
The large number of adjustable parameters in a clinical proton
therapy system (e.g., average energy, energy spread, spot size, beam
offset from central axis, etc.) demands a thorough sensitivity analysis
that provides important characteristics that are difﬁcult or impossible
to measure. In addition, the routine quality assurance processes can
be signiﬁcantly facilitated by correlating the adjustable simulation
parameters with measured dose distributions.
In this study, physical dose and LET distributions of a passive
double scattering compact proton therapy unit, known as Mevion
S250 (Mevion Medical Systems, Littleton, MA, USA), were calculated
using the Monte Carlo N‐Particle eXtended (MCNPX) MC code. The
physical dose results were benchmarked with measured commission-
ing data. Additionally, a sensitivity analysis of the Mevion S250 unit
was done by adding small variations of treatment nozzle and proton
source parameters and characterizing their impact on the depth of
the pristine peak, shape, and symmetry of the resulting dose proﬁles,
and LET distribution in a water phantom.
The aim of this work is to present guidance on the correlation
between treatment nozzle and proton source parameters, and physical
dose distribution to the following: for researchers modeling clinical pro-
ton beam systems, and clinical medical physicists tasked with physically
tuning their passive double scattering compact proton therapy unit to
bring beam parameters to within clinically acceptable levels. Moreover,
this work proposes to create a reference library to troubleshoot of the
machine installed and commissioned in the S. Lee Kling Proton Therapy
Center at Barnes‐Jewish Hospital in St. Louis, MO, USA.
To the best of our knowledge, this is the ﬁrst reported simulation
and sensitivity analysis of the Mevion S250 using MCNPX. The
Mevion S250 machine is particularly noteworthy because of its
unique beam characterization, which is due to the lack of energy
selection and beam transportation systems, and mounting interest in
single‐room proton unit.17
2 | MATERIALS AND METHODS
2.A | MCNPX MC simulation of Mevion S250
2.A.1 | Physical dose
The Mevion S250 has 24 different beam options divided into large,
deep, and small groups.2 Each beam conﬁguration is generated using
a unique arrangement and combination of different beam line compo-
nents (Fig. 1). In order to acquire physical dose distribution data for
each conﬁguration, three sets of measurements are taken: (a) pristine
peak, (b) lateral proﬁles in air, and (c) spread out Bragg peak (SOBP).
To obtain pristine peaks and SOBPs, a parallel‐plate chamber
(PPC05, IBA Dosimetry) was used to measure percent depth‐dose
curves in a 3D scanning tank (Blue phantom, IBA Dosimetry America,
Bartlett, TN, USA) at nominal source‐to‐surface distance (SSD) of
200 cm with radiation isocenter placed on the water surface. Lateral
proﬁles in air were measured using a diode Edge detector (Sun Nuclear
Corporation, Melbourne, FL, USA). The general guideline for acquiring
beam data for photon machines has been described in the report of
AAPMTask Group 106.18
For the MC simulations, MCNPX was used in this work.19 Com-
putations were performed using the facilities at the Washington
University, Center for High Performance Computing. The simulation
was started by using the manufacturer’s speciﬁcations for all dimen-
sions and materials of each beam component. Then, average energy,
energy spread (FWHM), spot size, and First Scatter (FS) thickness
were tuned to match the measured data (experimental results).
For SOBP simulations, a user deﬁned beam current modulation
(BCM) sequence was deﬁned considering the rotation angle of the
range modulator wheel.10,20 According to the method described by
Polf et al. individual pristine Bragg peaks were created and weighted
to form a uniform and ﬂat SOBP with the desired modulation.10
For the pristine peak and lateral proﬁles, for each dose point,
MCNPX derived data were compared with the measurements by cal-
culating the local difference. In addition, for the penumbra region of
the proﬁles, distance between the 80% and 20% dose levels was
compared. SOBP was evaluated by comparing the simulated results
and measured data, on the SOBP width as deﬁned by the proximal
95% to the distal 90% dose, beam range, and the depth of distal
20% dose. The beam range was deﬁned as the depth of 90% dose
(D90%) on distal fall‐off.
The simulations in water and air were performed with 2.0 × 109
and 7.5 × 108 histories respectively. Generally, for the so‐called “good
practice” in MC simulations, enough history should be calculated to
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ensure that MC results have at least 1σ (k = 1, 67% conﬁdence index)
<1% statistical uncertainty at depths of interest in the water and air.19
The mesh tally detector was used due to its functionality for pro-
ton dose calculations.19 The photons, electrons, protons, and posi-
trons were suppressed for simulations with a cutoff energy of
990 eV, 57.3 keV, 5 keV, and 56.6 keV respectively.
For comparison purposes, the results were then compared with
the derived values from TOPAS (version 2.0) simulations.20
2.A.2 | LET
After tuning the treatment nozzle for all the 24 options, both
track‐averaged LETt and dose‐averaged LETd, were calculated
according to the method by Guan et al.7 It should be noted that,
LETt calculated as the arithmetic mean value of the ﬂuence spec-
trum, matches the deﬁnition by the ICRU, and LETd is a quantity
that accounts for both physical dose and LET, to predict biological
effects.7,19
To calculate both LETt and LETd, the detector cells were mod-
eled as spheres on the central axis of the beam in water phantom.
The MCNPX LET special tally was employed to record ﬂux over the
cells as a function of stopping power instead of energy.19 Using this
tally, the recorded values in the energy bins are interpreted as stop-
ping power values (units of MeV/cm).
3 | SENSITIVITY ANALYSIS
The sensitivity of the model to changes in machine proton source
parameters was analyzed by varying the Average Energy (AE), Energy
Spread (ES), Spot Size (SS), Beam Angle (BA), and Offset from central
Axis (OA). FS thickness was the only treatment nozzle parameter used
for the sensitivity investigations. In this step, all 24 options of Mevion
S250were simulated in different stages to obtain the uncertainty of the
derived results on the depth of the pristine peak, shape, and symmetry
of the resulting dose proﬁles, as well as LETt and LETd distributions. For
the depth of pristine peak, the dose distribution was evaluated using
the distal 90% (D90%). Because, each SOBP was created by superim-
posing single Bragg peaks, the sensitivity study of the pristine peaks
also reﬂects uncertainties associated with SOBPs.10,13,15 The ﬂatness
and symmetry of the proﬁles were analyzed using themethod proposed
by Prusator et al.20 as follow:
Flatness ¼ Dmin  Dmaxð Þ= Dmin þ Dmaxð Þ  100 (1)
where, Dmin and Dmax are, respectively, the minimum and maximum
doses within the central axis of the beam to the 80% dose levels.
Symmetry ¼ LDintegral  RDintegral
 
= LDintegral þ RDintegral
   100 (2)
where, LDintegral and RDintegral are the integral doses of the left and
right side of the radiation ﬁeld respectively.
The stages included in the sensitivity study were the AE (±9%),
the ES (FWHM) [up to +20%], SS (up to +7 mm), BA (0°–2°), OA,
and SO (up to +15 mm), and increasing FS thickness (10%). The vari-
ations in each stage revealed the potential uncertainties in these
parameters. These uncertainty values were chosen based on clinical
operation, representing the likely extent of adjustments required to
bring a system to within acceptable tolerances.
Since for each group (large, deep, and small), treatment nozzle
conﬁgurations are very similar in design, in this study we will only
refer to the group, instead of the option, for the sensitivity analysis.
F I G . 1 . A cross‐section view of the
simulated Mevion S250 treatment nuzzle
for the deep group (distance from the
proton source to the isocenter was
205 cm).
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4 | RESULTS
With the number of simulated histories used, the uncertainty asso-
ciated with statistical (quantum) uncertainty in the MC‐calculated
results in air was less than 0.50% at all distances in the transverse
plane. For the large group, the statistical uncertainty for calculations
in water was less than 0.61% for the depths of 25.0 cm (D90% of
the deepest Bragg Peak). Whereas, for the deep and small groups,
it was 0.94% and 0.69% for D90% of 31.9 and 20.0 cm, respec-
tively.
This statistical uncertainty made it feasible to investigate notice-
able effects on the physical dose distribution due to slight changes
of the sensitivity study parameters. In other words, high precision
was obtained in the results of the simulations, which was due to
simulating large numbers of histories.
4.A | Physical dose and LET
For the pristine peak, the MCNPX MC model of the Mevion S250
matched measurements data for all the 24 options to within 2% of
the dose points compared and 1 mm for the distances to agreement
(within 2% or 1 mm criterion). Table 1, shows comparison of derived
percent depth dose data with MCNPX, for the large, deep, and small
options, with measurements and TOPAS simulations for this system.
Comparing the MCNPX and TOPAS results, there were differences
of up to 1.4% in the derived DD0.5 cm, the largest discrepancies
occurring in the deep options.
Fig. 2 illustrates a comparison between the derived lateral beam
proﬁles in this study with the measured values, where only the
data for options 6, 13, and 24 are presented for the sake of brev-
ity. The largest dose discrepancy between MC calculations and
measurements was 2% and in the penumbra region, whereas,
between the 80% and 20% dose levels the distance‐to‐agreement
was less than 1.0 mm. For the TOPAS simulations, the absolute dif-
ferences in the penumbras between simulated and measured pro-
ﬁles at each depth for each conﬁguration all agreed to well within
0.6 mm.
Flatness and symmetry of the proﬁles for the large group were
less than 1.44% and 0.40%, respectively, whereas, for the deep
group they were 1.18% and 0.30%, respectively. Small group
showed the lowest ﬂatness and symmetry (2.18% and 0.60%,
respectively).
For all the SOBPs, the distal 90% and 20% depths were
matched with measurements within 1.0 and 1.7 mm differences,
respectively. For width of the created SOBPs, the largest discrep-
ancy was less than 2.0 mm compared to the experimental mea-
surements.
Based on the treatment nozzle benchmarking results, for all the
24 options, the primary proton source energy was ﬁnally set to be
252 MeV with an initial Gaussian distribution proﬁle in energy (σE =
0.40 MeV) and in space (σx = σy = 2.7 mm). The nominal energy
provided by the vendor was 250 MeV and the energy spread was
0.4% (RMS).
The Mevion S250 was found to have a LETt between 0.46 and
8.76 keV.μm–1 and a corresponding LETd between 0.84 and
15.91 keV.μm–1. The distributions of LETt and LETd as a function of
depth for options3, 14, and23 are shown inFig. 3. After thedistributions
of LETt and LETd for each option were established for a single Bragg
peak, it was easy to superimpose several LETt and LETd for more com-
plex situations, according to thedeﬁnedBCMfor eachBraggpeak.21
4.B | Sensitivity analysis
4.B.1 | Average energy
In this study, using the 250 MeV nominal beam energy of the sys-
tem, the predicted D90% was within 3 mm for the small group, com-
pared to the experimental measurements. For the large and deep
groups, even less discrepancy (<2 mm) was seen.
Fig. 4, illustrates the absolute difference between the measured
and MC derived depth of D90% as a function of changes in the AE
for each group (large, deep, and small). As expected, there were dif-
ferences among these groups since each group uses a unique treat-
ment nozzle conﬁguration. Slight changes in the AE (3%) signiﬁcantly
inﬂuenced the D90% (up to 26.6 mm) for small group. Whereas, for
the large and deep groups, up to 23.4 and 22.1 mm, respectively,
changes of the D90% was observed. Moreover, the deep group was
less sensitive to 9% AE uncertainty (up to 57.3 mm), compared to the
large (58.8 mm) and small groups (61.1 mm).
Altering the proton beam energy to 109% showed a strong
effect on the small group proﬁle ﬂatness (up to 8.6%), whereas
results on the symmetry of the proﬁles were not signiﬁcant (less
than 2.2%) and remained within the statistical uncertainty of the MC
calculations. Figure 5, demonstrates the variations of the ﬂatness
and symmetry of lateral proﬁles for the small group due to 9%
increase in the AE.
4.B.2 | Energy spread (FWHM)
Figure 6, shows the absolute difference between the baseline and sen-
sitivity derived width of the pristine peaks and peak‐to‐plateau ratios
(peak‐to‐plateauSensitivity/peak‐to‐plateauBaseline) of the studied groups
(large, deep, and small). Due to 20% increase in the ES, the maximum
increase in the width of the pristine peaks were 4.1 and 2.9 mm for the
large and deep groups respectively, whereas, the maximum decrease in
the peak‐to‐plateau ratio were 4.5% and 1.6%, respectively. For the
small group, the maximum differences for the width of the pristine
peaks and peak‐to‐plateau ratios were 4.4 mm and 9.5%, respectively.
4.B.3 | Spot size
It was revealed that changes of the SS resulted in no signiﬁcant
effect on the pristine peaks D90% (<1 mm). Figure 7 gives the
changes of distal width and peak‐to‐plateau ratio of the pristine
peaks due to uncertainty associated with SS in large, deep, and small
groups. It was observed that, considering up to 3 mm uncertainty of
the SS, there was no signiﬁcant effect on the distal width (<1 mm)
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and peak‐to‐plateau ratio (<1%) owing to the beam spot size change.
In our study, the distal width of a Brag peak was deﬁned as the dif-
ference between the 10% and 90% dose on the distal fall‐off.
Noticeable effect on the distal width (about 2 mm) was seen for SS
of 10 mm, especially for the small group (Fig. 7).
Therefore, the beam SS have little inﬂuence on pristine peaks
and the effects might be too subtle to produce signiﬁcant changes
to the distal width of the dose distribution.
Varying the proton beam SS resulted in negligible effect (<1%)
on the ﬂatness and symmetry of the small group. The changes for
the large and deep groups were also remained approximately within
the statistical uncertainty of the calculations.
4.B.4 | Beam angle
Figure 8 shows that the 2° incident angle of the proton beam had a
signiﬁcant effect on the peak‐to‐plateau ratio (up to 4.5% decrease)
of the Bragg peaks, whereas, the effects on the depth of D90%
were small (<1 mm).
On the other hand, a 0.6° deviation from normal was found to
change the ﬂatness by 2.7% for small group and 1.8% for deep
group (Table 2). The maximum effect was seen for the small group
(up to 7.6%) for a 2.0° proton beam deﬂection. The symmetry was
less affected by the BA, as to see a 2.0% decrease in the ﬂatness of
the proﬁles; the proton beam should be deﬂected by a minimum of
0.6° for the small option. For the large and deep options, more beam
deﬂection was needed (>0.9°) to reproduce a same effect. The 2%
criterion for the ﬂatness and symmetry was selected to present the
likely level of adjustments needed to bring a proton system to within
acceptable clinical speciﬁcations. Moreover, it may be of an interest
for tuning a MC simulation of clinical proton systems.
4.B.5 | Offset from central axis
For a given lateral offset of 3 mm, the beam ﬂatness and symmetry
were signiﬁcantly affected, more strongly, for small (3.7% and 3.3%)
and large (3.5% and 2.8%) groups, compared to the deep group
(2.4% and 2.4%). As expected, increasing the OA for up to 15 mm
TAB L E 1 Comparison of derived percent depth dose data with MCNPX, for the large, deep, and small options, with measurements and
TOPAS simulations.20 Data are presented for dose at depth of 0.5 cm (DD0.5 cm) and 3.0 cm (DD3.0 cm) and the beam range, deﬁned as the
depth of 90% dose (D90%) on distal fall‐off.
Option ΔDD0.5 cm (%)
ΔDD0.5 cm (%)
[TOPAS] ΔDD3.0 cm (%)
Measured
D90% (cm) Δa in D90% (cm)
Δ in D90% (cm)
[TOPAS]
Large group 1 1.4 0.8 1.0 24.95 0.02 0.04
2 0.7 0.8 0.6 22.63 0.03 0.05
3 1.1 0.4 1.1 20.96 –0.06 ‐0.05
4 1.5 0.5 1.6 18.82 0.04 0.07
5 0.7 1.1 0.5 16.84 0.05 0.06
6 1.7 1.5 1.4 14.87 –0.05 0.04
7 0.8 1.0 1.7 13.16 0.04 0.05
8 0.6 0.6 0.6 11.45 0.04 ‐0.09
9 1.6 1.2 1.4 10.07 0.04 0.05
10 1.2 0.5 1.2 8.66 0.03 0.09
11 0.2 1.5 0.4 7.35 0.04 0.08
12 1.7 1.3 1.6 6.13 0.05 0.09
Deep group 13 1.9 1.2 1.5 31.95 0.03 0.04
14 0.4 0.6 0.5 29.48 0.04 0.00
15 1.1 1.6 0.8 26.94 0.03 0.02
16 0.4 1.8 0.4 24.49 0.04 0.03
17 0.9 1.1 1.2 22.12 0.04 0.04
Small group 18 1.4 1.5 1.3 20.06 0.03 0.05
19 0.4 1.9 0.6 17.81 –0.06 0.07
20 1.3 0.3 1.3 15.43 0.03 0.07
21 1.6 1.5 0.8 13.36 0.02 0.02
22 0.8 1.7 1.3 11.18 –0.03 0.04
23 1.1 0.6 1.0 9.10 –0.05 0.00
24 0.3 1.2 0.6 7.01 –0.05 0.00
Avg. (Max) 1.03 (1.9) 1.09 (1.9) 1.01 (1.7) 0.039(0.06) 0.048 (0.09)
aDiscrepancy (D90% Measurement – D90% MCNPX Simulation).
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signiﬁcantly decreased ﬂatness and symmetry of the proﬁles, espe-
cially for small option (31.0% and 11.4%). Figure 9 gives variations
of the ﬂatness and symmetry of the large group proﬁles due to
uncertainty in the OA. Similar results were observed for the SO. In
other words, considering the statistical uncertainty of the MC
results, OA was indistinguishable from SO. Figure 10 shows changes
in the ﬂatness and symmetry of the proﬁles due to uncertainty asso-
ciated with SO from the central axis.
Moreover, 3–15 mm OA resulted in change of D90% (up to
3 mm). According to our results, small groups was found to be more
sensitive on the OA and SO small changes compared to the other
treatment nozzle conﬁgurations.
4.B.6 | First Scatter thickness
In this work, it was hypnotized that changes in the thickness of the
lead FS have a much more prominent effect on the depth of D90%.
The maximum thickness of the FS is 8.370 mm (large group‐ option
12) to 1.322 mm (deep group‐ option 17) depending on the treat-
ment nozzle conﬁguration. Therefore, options 1 and 13 with corre-
sponding FS thickness of 6.167 mm and 1.322 mm, respectively,
were selected for the sensitivity analysis.
For the small group, there is no FS in the treatment nozzle con-
ﬁguration; therefore, we were unable to investigate the sensitivity of
the derived dose distribution due to uncertainty in FS thickness. Fig-
ure 11 gives the changes of the depth of D90% as a function of FS
thickness for large and deep options. Changes in FS thickness affect
the range, especially for the large group (up to 5 mm).
Increasing the FS thickness within the tolerances in this study
(up to 10%), had a comparatively minor effect on the proﬁle ﬂatness
and symmetry (less than 2%).
4.B.7 | LET
For the small group due to 9% increase in the AE, in the peak region
the LETd decreased by up to 2.03 keV/μm−1 representing 12.8% of
its maximum value, whereas LETt was decreased by up to 1.59 keV/
μm−1 (14.6% of its maximum value). In the plateau region, LETd and
LETt were less affected (up to 4.9% and 2.7%, respectively). In other
words, LETt was less sensitive than the LETd by up to 2.2%. For this
group, the plateau maximum values of the LETd and LETt were
F I G . 2 . Comparison between the MCNPX derived (red) and
measured (black) lateral beam proﬁles for options 6 (large group), 13
(deep group), and 24 (small group). The lateral beam dose proﬁles for
options 13 and 24 are multiplied by 0.8 and 0.6, respectively, to
show all three comparisons in one graph.
F I G . 3 . Distributions of LETt (green) and
LETd (blue) as a function of depth for each
main Bragg peak of the options 3 (large
group), 14 (deep group), and 23 (small
group).
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0.89 keV/μm−1 and 0.54 keV/μm−1 respectively. For the small group,
slight changes in the AE (<3%) did not signiﬁcantly inﬂuence the
LETs (less than 2%). Our results showed that, deep group was less
sensitive in the both peak (<4.7%) and plateau (<2%) regions com-
pared to the small group. For deep group, the maximum values of
the LETt and LETd were 6.97 keV/μm−1 and 13.42 keV/μm−1 respec-
tively. The maximum values of the LETd and LETt in the plateau
were 0.84 keV/μm−1 and 0.46 keV/μm−1 respectively. Figure 12,
illustrates changes of the LETt and LETd distributions due to 3% and
5% increase in the AE for the large group.
As ES becomes larger (up to 20%), for all the groups, the absolute
maximum of LETd and LETt become lower (up to 1.67 keV/μm−1 and
1.23 keV/μm−1, respectively), and less steep at the end of the range
(Fig. 13). Increasing the ES resulted in decrease in LETt and LETd for
the peak regions, especially for the small group (up to 9.2% and 9.
6% respectively). For the deep group, decrease in the LETt and LETd
was remained within less than 1% of their maximum values. Both
LETt and LETd in the plateau region were even less sensitive (<1%) to
changes in the ES within the uncertainties studied in this work. Fig-
ure 13, shows the variations in the LETd (dash line) and LETt (solid
line) distributions due to increase in the ES for the large option.
Due to 7 mm increase in the SS, the maximum decrease in the
LETd and LETt for the large group was up to 0.56 keV/μm−1and
0.34 keV/μm−1, respectively, representing 4.1% and 4.8% of their
maximum value. For this group, up to 5 mm increase in the SS,
resulted in slight changes of the LETs (<2%). For the deep group,
changes were within 1% of their maximum values. For small and
large groups, both LETd and LETt were less steep at the end of the
range (Fig. 14). Figure 14, shows variations of the LETt and LETd dis-
tributions due to increase in the SS for the small group. For all the
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groups, similar to ES, changes in the plateau region were not signiﬁ-
cant (<1%).
5 | DISCUSSION
There is no literature available on the sensitivity analysis of physical
dose and LET distributions of Mevion S250 as a passive double scat-
tering compact proton therapy unit.
The MCNPX benchmarked physical dose with the measured data
showed up to 2% or 1 mm discrepancy (Table 1; Fig. 2), mainly due
to the physical properties of various materials15 in the treatment
nozzle as well as uncertainty associated with the cross section
library,22,23 which were not evaluated in this work. However, it has
been stated that the default conﬁgurations, i.e. cross section library,
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TAB L E 2 Variations of the ﬂatness and symmetry of the proﬁles
due to changes of the incident angle of the proton beam.
BA (°)
Flatness (%) Symmetry (%)
Large
opt.
Deep
opt.
Small
opt.
Large
opt.
Deep
opt.
Small
opt.
0.3 1.88 2.05 3.44 1.0 1.10 1.54
0.6 3.1 2.38 4.17 1.38 1.41 1.82
0.9 4.32 2.66 4.65 1.74 1.54 2.14
1.2 4.78 3.2 5.13 2.27 2.05 2.45
1.5 5.65 4.34 6.43 2.48 2.36 2.77
1.8 6.89 5.76 7.15 2.59 2.47 3.01
2.0 8.5 6.78 8.78 2.85 2.58 3.52
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of the MCNPX MC code lead to results that are within to the clini-
cally used quality assurance criteria.24
Results of the MCNPX simulation were in reasonably good
agreement with the TOPAS simulations (<2% of the dose points
compared and <1 mm for the distances) (Table 1). Small differences
between the MCNPX and TOPAS, especially for the lateral beam
proﬁles, may be due to the shape of the aperture cut‐out, which was
relevant for penumbra region and was more difﬁcult to model accu-
rately in MCNPX. Zhao et al. observed noticeable differences along
the ﬁeld edges, both inside and outside of the ﬁelds, at shallow
depths. They stated that, the differences were signiﬁcantly
decreased with increasing depth in water.2
MCNPX model sensitivity analysis for all the options revealed
that, the AE and ES had the greatest effect on the D90% and peak‐
to‐plateau ratio (Figs. 4–6) respectively. Although, the AE of a proton
beam is not as of clinical interest as the range, since the range can
be measured very accurately,15 it should be known as starting points
for the MC simulations. The ES can provide one of the largest
sources of uncertainty in simulation due to the difﬁculty in measur-
ing it. Similar to our ﬁndings, it has been reported that, the ﬁnite
width and peak‐to‐plateau ratio of the Bragg peak is very sensitive
to the ES of the proton beam.13,15 It should be noted that, for a pro-
ton system, the relationship between AE and ES is not known accu-
rately. Our results were in a good agreement with Paganetti et al.13
who simulated the Francis H Burr proton beam treatment nozzle, at
the Northeast Proton Therapy Center at Massachusetts General
Hospital, to aid in the commissioning process and support clinical
operation. They found that, increasing the energy spread results in
the broadening of the Bragg peak and consequently decrease in the
peak‐to‐plateau ratio. Bednarz et al. stated that change in beam
energy spread does not have a noticeable effect on the uniformity
of the SOBP.15 We found that, for the Mevion S250, variations of
the proton ES had no signiﬁcant effect on the ﬂatness and symmetry
of the beam proﬁle for the large and deep groups. For the small
group, up to 2.6% decrease in the beam ﬂatness was observed due
to 20% change in the ES.
On the other hand, it has been reported that, the beam SS may
inﬂuence the peak‐to‐plateau ratio of pristine Bragg peaks, and
accordingly the SOBPs uniformity.15 Some publications have shown
that the beam spot size adjustments can be based on the steepness
of the distal fall‐off and the peak/plateau ratio, both being quite sen-
sitive to this parameter.10,13 For the Mevion S250 proton system,
we observed up to 2 mm increase in the distal width of the pristine
peaks due 7 mm increase in the SS, especially for the small group
(Fig. 7).
We found that BA, OA, and SO signiﬁcantly decreased the ﬂat-
ness and symmetry of the proﬁles (Figs. 8–10). Up to 2.0° tilt of pro-
ton beam resulted in nonsigniﬁcant effect on the D90% (<1 mm),
while variations in the peak‐to‐plateau ratio were signiﬁcant (Fig. 8).
For the Mevion S250, the slope of the lexan and lead layers of sec-
ond scatter are greater near its central axis.2 Therefore, slight
changes in the beam SO (3 mm) produced signiﬁcant uncertainty on
the shape of the proﬁles, for all the studied options. The minimum
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OA required to induce a 2% change in symmetry was roughly 25%
greater for the large option than for the small conﬁguration (Table 2).
Moreover, ﬂatness of the proﬁle was more sensitive to SO and OA
changes near the central axis than in the periphery of the ﬁeld, espe-
cially for small options. For deep group, the 5 mm OA from the cen-
tral axis can signiﬁcantly change the symmetry of the proﬁle (up to
7.5%), while for small group lesser changes of OA (4 mm) was
needed to produce a same effect (Figs. 8 and 9). This results in
another source of uncertainty that can be included in a reference
library guiding clinical medical physicists and engineers to trou-
bleshoot and repair the machine, and also to tune the beam parame-
ters to within clinically acceptable levels. Therefore, the proton beam
line and second scatter must be taken into account as a system to
evaluate changes in the shape of the proﬁles. While for a proton
system already in clinical use, determining reasonable tolerances in
all the moving parts in the beamline can be difﬁcult, some
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measurements, i.e. beam proﬁle due to second scatter offset, during
acceptance testing of a new system may be helpful for later Monte
Carlo commissioning work.
In addition to the uncertainties studied in this work, physics con-
stants of various materials used in the construction of the treatment
nozzle may produce another source of uncertainty.16 Previous stud-
ies have shown a signiﬁcant sensitivity in MC calculated dose distri-
bution on the variations in properties of materials used in passive
scattering proton therapy treatment nozzles.15 Based on the sensitiv-
ity study performed on IBA (Louvain‐la‐Neuve, Belgium), the authors
have reported that slight changes in density of the materials of ﬁeld
shaping parts clearly inﬂuenced the range and uniformity of dose
distribution.15
These results can be used to improve quality assurance proce-
dure or speed up commissioning process, especially for the commis-
sioning of MC models of clinical passively scattered proton beams.
Commissioning a MC model of a passively scattered proton can be a
more rigorous and difﬁcult process than it is for more standard treat-
ment planning softwares. Correlating the many adjustable simulation
parameters of the nuzzle with measurable dose distributions can
notably facilitate the commissioning process. Moreover, to speed up
the quality assurance of this system our results are an effective
means of relating nuzzle parameters to clinical measurements.
The RBE of proton therapy is a function of dose, tissue endpoint,
and energy deposition characteristics.4 In this regard, the LET can be
used to parameterize the latter for proton beams, by taking into
account range uncertainties, for a given dose and biological end-
point.3,6 It is known that, the LET distribution in a proton beam
depends on the range,25 therefore, uncertainty associated with range
may affect LET distribution. In this study, it was hypothesized that
changing the beam parameters including; AE, ES, and SS, alters the
LETt and LETd distribution for a given proton beam. Generally, it is
known that LETt and LETd are less sensitive in the plateau region,
however, both LETs are highly sensitive to variations in energy near
the Bragg peak when proton energy become low.3,7 It has been sta-
ted that, for the passive‐scattering unmodulated monoenergetic pro-
ton beams of 250 MeV at the Proton Therapy Center at Houston
(PTCH), LETt is between 0.45 and 5.95 keV.μm–1.26 For proton
beamlet of 201 MeV, the maximum LETt and LETd were reported to
be 10.4 and 15.3 keV.μm–1, respectively, signiﬁcantly higher, as
expected, than the values calculated in our work.7
In our study, considering the sensitivity study of the LET, it was
found that in the peak region, depending on the option, both LETt
and LETd were sensitive to changes of AE, ES, and SS (Fig. 12–14).
However, compared to the LETd which showed higher sensitivity in
the plateau region, LETt showed higher sensitivity in the peak (up to
1.8%).
According to the previous reports for biological dose calculations,
LETd is more appropriate than the LETt at therapeutically relevant
dose levels.3 On the other hand, the proton biology experiments
have shown the role of LET in the plateau region for determining
cell kill is small.7 Therefore, in line with previous recommendation of
Guan et al.3, we recommend the use of LETt in the dose plateau
region due to its characteristics of continuous increase along beam
path and lower sensitivity to beam uncertainties. It means that a
spatially variant switch between the use of LETt and LETd to quan-
tify the LET is recommended for biological studies.
Recently, the idea of adaptive treatment planning by LET painting
has started its development in the framework of TPS.4 Based on this
idea, for a passively scattered proton treatment plan, optimization
algorithm can attempt to minimize the volume of normal tissues
exposed to high LETd, resulting in reducing radiation‐induced toxicity.
6 | CONCLUSIONS
This study presents a detailed sensitivity analysis of most important
but often poorly speciﬁed beam parameters required for simulating a
gantry‐mounted passively scattered proton system. Our results
revealed the importance of these parameters specially those resulted
in large effects on the physical dose distribution and/or LETs, i.e.,
average proton beam energy, initial energy spread, spot size, and off-
set from the central axis. The ﬁndings can be used as a useful tool
when quality assurance of this system. Moreover, the sensitivity
analysis can also be used to aid machine design for determining rea-
sonable tolerances in all the moving parts in the beamline. The simu-
lation results from the sensitivity analysis can be utilized to
construct a reference library to guide troubleshooting and repairing
for the machine as well.
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